2-溴-1-(3-(三氟甲基)苯基)乙酮 | 2003-10-3

• 物质功能分类: 有机原料 - 酮类化合物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-溴-1-(3-(三氟甲基)苯基)乙酮
• 中文别名: 2-溴-3'-(三氟甲基)苯乙酮；3-(三氟甲基)苯甲酰甲基溴；3-三氟甲基-A-溴代苯乙酮；2-溴-3-三氟甲基苯乙酮；2-溴-3-(三氟甲基)苯乙酮
• 英文名称: 2-bromo-1-[3-(trifluoromethyl)phenyl]ethanone
• 英文别名: 2-bromo-1-(3-(trifluoromethyl)phenyl)ethan-1-one；α-bromo-3-trifluoromethylacetophenone；2-bromo-3'-trifluoromethylacetophenone；3-(trifluoromethyl)phenacyl bromide；α-bromo-m-trifluoromethylacetophenon；2-bromo-1-[3-(trifluoromethyl)phenyl]-1-ethanone；2-Bromo-1-(3-(trifluoromethyl)phenyl)ethanone
• CAS: 2003-10-3
• 化学式: C₉H₆BrF₃O
• mdl: MFCD03094283
• 分子量: 267.045
• InChiKey: TZIYNLSEBAYCBZ-UHFFFAOYSA-N

物化性质

• 熔点：
  22°C
• 沸点：
  64-72°C
• 密度：
  1.592±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险品标志：
  C
• 危险类别码：
  R34
• 危险品运输编号：
  UN 1760
• 海关编码：
  2914700090
• 安全说明：
  S26,S36/37/39,S45
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P301+P330+P331,P280,P305+P351+P338,P310
• 危险性描述：
  H314
• 储存条件：
  室温

SDS

Name:	2-Bromo-1-[3-(trifluoromethyl)phenyl]-1-ethanone tech Material Safety Data Sheet
Synonym:
CAS:	2003-10-3

Section 1 - Chemical Product MSDS Name:2-Bromo-1-[3-(trifluoromethyl)phenyl]-1-ethanone tech Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
2003-10-3	2-Bromo-1-[3-(trifluoromethyl)phenyl]-		unlisted

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns. Lachrymator (substance which increases the flow of tears).
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area. Store under an inert atmosphere.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 2003-10-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: pale yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 64 - 72 deg C @0.1mbar
Freezing/Melting Point: 22 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H6BrF3O
Molecular Weight: 267.04

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide, bromine, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 2003-10-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Bromo-1-[3-(trifluoromethyl)phenyl]-1-ethanone - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3261
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 2003-10-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 2003-10-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2003-10-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

2-溴-1-(3-(三氟甲基)苯基)乙酮是一种含三氟甲氧基的化合物，具有较高的膜渗透性、抗代谢稳定性及与脂膜的亲和力、热稳定性和化学稳定性等特点。该物质被广泛应用于医药化工行业。

制备

将尾气吸收装置、回流冷凝管和温度计安装在100 mL三颈烧瓶中，依次加入1-(3-(三氟甲基)苯基)乙酮、溴酸钠、溴化钠和四氯化碳。搅拌并加热至回流状态，缓慢滴加1/2体积的硫酸（60 mmol 浓硫酸用2 mL水稀释所得），通过气相色谱跟踪反应进程。当底物完全参与反应后约1小时，迅速加入1/3体积的引发剂溶液（1.1 g偶氮二异庚腈溶解于7 mL四氯化碳中）。体系出现剧烈回流后，继续缓慢滴加剩余的引发剂溶液和硫酸，约4.5小时内完成。当产物不再形成或副产物明显增加时（约1.5小时），将反应液降至室温并进行过滤。有机相用10 mL 5%碳酸氢钠溶液洗涤、分液，再经无水硫酸钠干燥和浓缩后得到粗产品。最后，通过柱层析纯化（乙酸乙酯：石油醚=1:20）的洗脱液洗脱并进一步浓缩，可获得纯净的2-溴-1-(3-(三氟甲基)苯基)乙酮。

反应信息

• 作为反应物：
  描述：

  2-溴-1-(3-(三氟甲基)苯基)乙酮 在 platinum(IV) oxide 氢气 、 对甲苯磺酸 作用下， 以 溶剂黄146 、 甲苯 、 苯 为溶剂， 反应 44.0h， 生成 丙吗啉氟苄
  参考文献：
  名称：

  Heterocycles. 8. Synthesis of oxaflozane

  摘要：

  DOI：

  10.1021/jo01312a037
• 作为产物：
  描述：

  间三氟甲基苯乙酮 在 polymer-supported pyridinium bromide perbromide 作用下， 以 甲苯 为溶剂， 生成 2-溴-1-(3-(三氟甲基)苯基)乙酮
  参考文献：
  名称：

  使用聚合物支持的试剂三步合成一系列取代的苯并呋喃

  摘要：

  通过用聚合物负载的溴化吡啶鎓过溴化物（PSPBP）将苯乙酮溴化为α-溴苯乙酮，可以实现一种有效的组合方法，以取代3-苯基苯并呋喃。随后使用1,5,7-三氮杂双环[4.4.0]癸-5-烯（TBD-P）将所得的溴化物彻底替换为苯酚，并使用Amberlyst 15将所得的α-苯氧基乙酰苯酮环化脱水，得到的纯产品不含需要任何色谱纯化步骤。

  DOI：

  10.1039/a904384e

文献信息

• Aminoalkylthiopyranopyrroles
  申请人：American Hoechst Corporation

  公开号：US03991076A1

  公开（公告）日：1976-11-09

  Aminoalkylthiopyranopyrroles and related compounds of the formula ##SPC1## In which R.sub.1, R.sub.2, R.sub.3, X, m, n and p are as defined below, and their physiologically tolerable acid addition salts are disclosed to possess antiinflammatory and antiarrhythmic properties. A process for their preparation is also disclosed.

  Aminoalkylthiopyranopyrroles及相关化合物的化学式如下所示：##SPC1## 其中R.sub.1, R.sub.2, R.sub.3, X, m, n和p的定义如下，并且其生理耐受性酸盐被披露具有抗炎和抗心律失常的特性。同时还披露了它们的制备方法。
• [EN] CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS DE LA CÉRAMIDE GALACTOSYLTRANSFÉRASE POUR LE TRAITEMENT DE MALADIES
  申请人：BIOMARIN PHARM INC

  公开号：WO2017214505A1

  公开（公告）日：2017-12-14

  Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

  本文描述了化合物、制备这种化合物的方法、含有这种化合物的药物组合物和药物、以及使用这种化合物治疗或预防与酶神经鞘糖脂转移酶（CGT）相关的疾病或紊乱的方法，例如溶酶体贮积症。溶酶体贮积症的例子包括 Krabbe 病和白质变性白血病。
• Method of treatment with and compositions containing condensed pyrroles
  申请人：American Hoechst Corporation

  公开号：US03931407A1

  公开（公告）日：1976-01-06

  Novel N-phenylpyrroles are disclosed that are effective in the treatment of inflammation and pain in mammals and have the formula ##SPC1## Wherein R is hydrogen, alkyl of one to six carbon atoms, thienyl, phenyl or phenyl substituted by halogen, trifluoromethyl, alkyl of one to six carbon atoms, alkoxy of one to six carbon atoms, alkanoyloxy of one to six carbon atoms, alkanoylamino of one to six carbon atoms, nitro, cyano, hydroxyl, amino or phenyl; R.sub.1 is carboxyl, alkoxycarbonyl of two to seven carbon atoms, carbamoyl, N-alkylcarbamoyl of two to seven carbon atoms, N,N-dialkylcarbamoyl of three to seven carbon atoms, hydroxycarbamoyl or dialkylphosphinylalkoxycarbonyl of four to 10 carbon atoms; R.sub.2 is hydrogen, hydroxyl, mercapto, halogen, trifluoromethyl, alkyl of one to six carbon atoms, alkoxy of one to six carbon atoms, alkanoyloxy of one to six carbon atoms, alkylthio of one to six carbon atoms, amino, alkylamino of one to six carbon atoms, dialkylamino of two to six carbon atoms, alkanoylamino of one to six carbon atoms, alkanoylthio of one to six carbon atoms, thiocarbamoyloxy, alkylthiocarbamoyloxy of two to six carbon atoms, dialkylthiocarbamoyloxy of three to seven carbon atoms, carbamoylthio, alkylcarbamoylthio of one to six carbon atoms, dialkylcarbamoylthio of two to seven carbon atoms, carbamoylamino, alkylcarbamoylamino of two to six carbon atoms or dialkylcarbamoylamino of three to seven carbon atoms; R.sub.3 is hydrogen, alkanoyl of one to six carbon atoms, or phenyl; X is alkylene of three to five carbon atoms, alkylene of three to five carbon atoms substituted by alkyl or alkoxy of one to six carbon atoms, divinylene, divinylene substituted by alkyl of one to six carbon atoms, ##SPC2## Wherein D is hydrogen, alkyl of one to six carbon atoms, alkoxy of one to six carbon atoms, alkanoyloxy of one to six carbon atoms, alkanoylamino of one to six carbon atoms, halogen, amino, nitro or trifluoromethyl; and n is 1 or 2.

  揭示了对哺乳动物的炎症和疼痛治疗有效的新型N-苯基吡咯类化合物，其化学式为##SPC1##其中R为氢、一至六个碳原子的烷基、噻吩基、苯基或被卤素、三氟甲基、一至六个碳原子的烷基、一至六个碳原子的烷氧基、一至六个碳原子的烷酰氧基、一至六个碳原子的烷酰胺基、硝基、氰基、羟基、氨基或苯基取代的苯基；R.sub.1为羧基、二至七个碳原子的烷氧羰基、氨基甲酰基、二至七个碳原子的N-烷基氨基甲酰基、三至七个碳原子的N,N-二烷基氨基甲酰基、羟基氨基甲酰基或四至十个碳原子的二烷氧羰基磷基；R.sub.2为氢、羟基、巯基、卤素、三氟甲基、一至六个碳原子的烷基、一至六个碳原子的烷氧基、一至六个碳原子的烷酰氧基、一至六个碳原子的烷硫基、氨基、一至六个碳原子的烷基氨基、二至六个碳原子的二烷基氨基、一至六个碳原子的烷酰胺基、一至六个碳原子的烷硫酰基、硫代羰氨氧基、二至六个碳原子的烷硫代羰氨氧基、三至七个碳原子的二烷硫代羰氨氧基、硫代羰氨硫基、一至六个碳原子的烷硫代羰氨硫基、二至七个碳原子的二烷硫代羰氨硫基、羰胺基、二至六个碳原子的烷羰胺基或三至七个碳原子的二烷羰胺基；R.sub.3为氢、一至六个碳原子的烷酰基或苯基；X为三至五个碳原子的烷基、被一至六个碳原子的烷基或烷氧基取代的三至五个碳原子的烷基、二烯基、被一至六个碳原子的烷基取代的二烯基，##SPC2##其中D为氢、一至六个碳原子的烷基、一至六个碳原子的烷氧基、一至六个碳原子的烷酰氧基、一至六个碳原子的烷酰胺基、卤素、氨基、硝基或三氟甲基；n为1或2。
• [EN] OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS OXADIAZINE ET LEURS MÉTHODES D'UTILISATION
  申请人：FORUM PHARMCEUTICALS INC

  公开号：WO2016201168A1

  公开（公告）日：2016-12-15

  The present disclosure relates to oxadiazine compounds, pharmaceutical compositions comprising an effective amount of an oxadiazine compound and methods for using an oxadiazine compound in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of an oxadiazine compound.

  本公开涉及恶二嗪化合物，包含有效量的恶二嗪化合物的药物组合物，以及使用恶二嗪化合物治疗神经退行性疾病的方法，包括向需要其的受试者施用有效量的恶二嗪化合物。
• Fast and Green One-Pot Multicomponent Synthesis of a Library of Pyrrolo[1,2-c] Pyrimidines Under Microwave Irradiation
  作者：Emilian Georgescu、Florentina Georgescu、Constantin Draghici、Liliana Cristian、Marcel Popa、Florea Dumitrascu

  DOI：10.2174/13862073113169990050

  日期：2013.11

  clean and rapid one-pot three component, microwave-assisted synthesis of pyrrolo[1,2-c]pyrimidine derivatives starting from various substituted pyrimidines, 2-bromoacetophenones and nonsymmetrical, electron deficient alkynes in 1,2-epoxybutane which acts both as solvent and acid scavenger is reported. This one-pot three component synthesis implies short reaction times being at the same time highly cost-effective

  一种简单，清洁，快速的一锅三组分微波辅助合成吡咯并[1,2-c]嘧啶衍生物，其由各种取代的嘧啶，2-溴苯乙酮和不对称的电子缺陷炔烃在1,2-环氧丁烷中起作用既有用作溶剂也有除酸剂的报道。这种一锅三组分的合成方法意味着反应时间短，同时具有很高的成本效益和环境友好性。